Inhibikase Therapeutics annual capital expenditures (capex)
2021
2022
2023
2024
2025
Inhibikase Therapeutics Capital Expenditures (CapEx) Growth & History (IKT)
Inhibikase Therapeutics's capital expenditures (capex) was $13,399 for fiscal 2025.
View full Inhibikase Therapeutics company overviewInhibikase Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $13,399 | $13,399 | — |
| 2024 | 2024-12-31 | $0 | −$14,238 | — |
| 2023 | 2023-12-31 | $14,238 | −$229,017 | −94.15% |
| 2022 | 2022-12-31 | $243,255 | $243,255 | — |
| 2021 | 2021-12-31 | $0 | — | — |
Inhibikase Therapeutics quarterly capital expenditures (capex)
Q3.21
Q3.22
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | −$13,399 | — |
| Q4 2025 | 2025-12-31 | $0 | $0 | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | $0 | — |
| Q1 2025 | 2025-03-31 | $13,399 | $13,399 | — |
| Q4 2024 | 2024-12-31 | $0 | — | — |
| Q3 2024 | 2024-09-30 | $0 | $0 | — |
| Q2 2024 | 2024-06-30 | $0 | — | — |
| Q1 2024 | 2024-03-31 | $0 | — | — |
| Q3 2023 | 2023-09-30 | $0 | −$200,166 | — |
| Q3 2022 | 2022-09-30 | $200,166 | $200,166 | — |
| Q3 2021 | 2021-09-30 | $0 | — | — |
Inhibikase Therapeutics capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, Inhibikase Therapeutics's capital expenditures (capex) increased from $0 to $13,399, a change of $13,399. The latest reported quarter, Q2 2026, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Inhibikase Therapeutics source filings ↗